Accolate
Company: AstraZeneca
Approval Status: Approved September 1999
Treatment for: Asthma in pediatric patients
Areas: Pulmonary/Respiratory Diseases
| General Information | Mechanism of Action |
General Information
Other Useful Resources
For the use of Accolate 10 mg oral Tablets for the prophylaxis and chronic treatment of asthma in pediatric patients 7 - 11 years of age.
Mechanism of Action
TabletThe FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Medical Dictionary Searches
